Back to Search
KARAM BHALLA MD
MD
Internal Medicine Physician
NPI: 1972642973Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
2005-0348(NM)MD2011-0813(NM)
Research & Publications (20)
Quantitative determination of gibberellins by high performance liquid chromatography from various gibberellins producing Fusarium strains.
PMID 19626451·Environ Monit Assess·2010
8-other
Adverse health outcomes of road traffic injuries in Iran after rapid motorization.
PMID 19400607·Arch Iran Med·2009
6-review
Data sources for improving estimates of the global burden of injuries: call for contributors.
PMID 19166263·PLoS Med·2009
8-other
Co-treatment with heat shock protein 90 inhibitor 17-dimethylaminoethylamino-17-demethoxygeldanamycin (DMAG) and vorinostat: a highly active combination against human mantle cell lymphoma (MCL) cells.
PMID 19440035·Cancer Biol Ther·2009
8-other
Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.
PMID 19638619·Blood·2009
8-other
Investigational drugs targeting FLT3 for leukemia.
PMID 19671038·Expert Opin Investig Drugs·2009
6-review
Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells.
PMID 19279403·Cancer Biol Ther·2009
8-other
p53 acetylation is crucial for its transcription-independent proapoptotic functions.
PMID 19265193·J Biol Chem·2009
8-other
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance.
PMID 19011628·Nat Immunol·2009
7-preclinical
Building national estimates of the burden of road traffic injuries in developing countries from all available data sources: Iran.
PMID 19494093·Inj Prev·2009
8-other
Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944).
PMID 18306034·Breast Cancer Res Treat·2009
3-trial
Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.
PMID 18986703·Leuk Res·2009
5-case
Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma.
PMID 19663825·Br J Haematol·2009
3-trial
Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.
PMID 19074726·Blood·2009
7-preclinical
Fire-related deaths in India in 2001: a retrospective analysis of data.
PMID 19250664·Lancet·2009
8-other
Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells.
PMID 18660379·Blood·2008
7-preclinical
HDAC6 inhibition enhances 17-AAG--mediated abrogation of hsp90 chaperone function in human leukemia cells.
PMID 18591380·Blood·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 4420 IRVING BLVD NW
ALBUQUERQUE, NM 87114 - Phone
- (505) 727-6300
Quick Facts
- NPI
- 1972642973
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile